NASDAQ:STAB

Statera Biopharma Stock Forecast

etoro logo Buy STAB
*Your capital is at risk
$0.0001
+0 (+0%)
At Close: Jun 05, 2026
AI Analysis AI Analysis of STAB AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add STAB to Watchlist?
  • Easy Tracking In The Watchlist
PDF

Statera Biopharma, Inc. stock price down 0% on Friday
(Updated on Jun 05, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Sell candidate since Jun 04, 2026

No changes to the price of Statera Biopharma, Inc. stock on the last trading day (Friday, 5th Jun 2026). During the last trading day the stock fluctuated 0% from a day low at $0.0001 to a day high of $0.0001. The price has been going up and down for this period, and there has been a 0% change for the last 2 weeks.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Due to the high volatility and the trend direction we are not able to give forecast range for this stock.

STAB Signals & Forecast

There are mixed signals in the stock today. The Statera Biopharma, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.0001 and $0.0001. A break-up above any of these levels will issue buy signals. Volume fell on the last day without any changes to the price. This does not cause any direct divergence but may be an early warning and a possible "turning point". The very low volume increases the risk and reduces the other technical signals issued. A buy signal was issued from a pivot bottom point on Wednesday, April 29, 2026, and so far it has fallen 0%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD).

Buy
Special Signal Notification

Double Bottom Formation

Double Bottom Formation A buy signal from a double bottom formation was found on Wednesday, April 29, 2026 and based on theory for this formation the price should go up by 400.00% to $0.0005 within 6 trading days (Thursday, May 07, 2026) since signal was issued.

Support, Risk & Stop-loss for Statera Biopharma, Inc. stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

In general the stock tends to have very controlled movements and therefore the general risk is considered very low. However, be aware of low or falling volume and make sure to keep an eye on the stock During the last day, the stock moved $0 between high and low, or 0%. For the last week the stock has had daily average volatility of 20.00%

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (STAB) For The Upcoming Trading Day Of Monday 8th

For the upcoming trading day on Monday, 8th we expect Statera Biopharma, Inc. to open at $0.0001, and during the day (based on 14 day Average True Range), to move between $0.000088236182 and $0.0001, which gives a possible trading interval of +/-$0.000023527637 (+/-26.66%) up or down from last closing price. If Statera Biopharma, Inc. takes out the full calculated possible swing range there will be an estimated 26.66% move between the lowest and the highest trading price during the day.

Is Statera Biopharma, Inc. stock A Buy?

Statera Biopharma, Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -1.679 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on June 8, 2026 - $0.0001 ( 0%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

STAB Performance

Trading levels for STAB

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 0.0001 -
R2 0.0001 -
R1 0.0001 -
Price 0.0001
S1 0.0001 -
S2 0.0001 -
S3 0.0001 -

Accumulated Volume Support & Resistance Levels

Level Price
R3 0 -
R2 0 -
R1 0 -
Price 0.0001
S1 0 -
S2 0 -
S3 0 -

FAQ

What is the symbol for Statera Biopharma, Inc. Stock and on which exchange is it traded?
The symbol for Statera Biopharma, Inc. is STAB and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Statera Biopharma, Inc. Stock?
Statera Biopharma, Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

How to buy Statera Biopharma, Inc. Stock?
Statera Biopharma, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Statera Biopharma, Inc. Stock.

What's the current price of Statera Biopharma, Inc. Stock?
As of the end of day on the Jun 05, 2026, the price of an Statera Biopharma, Inc. (STAB) share was $0.0001.

What is the 52-week high and low for Statera Biopharma, Inc. Stock?
The 52-week high for Statera Biopharma, Inc. Stock is $0.0006 and the 52-week low is $0.0001000000.

What is the market capitalization of Statera Biopharma, Inc. Stock?
As of the Jun 05, 2026, the market capitalization of Statera Biopharma, Inc. is 7.142K.
Click to get the best stock tips daily for free!
ABOUT STATERA BIOPHARMA, INC.
Statera Biopharma
Statera BioPharma, Inc., a clinical-stage biopharmaceutical company, develops novel immunotherapies targeting autoimmune, neutropenia/anemia, emerging viruses, and cancers based on a proprietary platform designed to rebalance the body's immune system and restore homeostasis. The company is developing therapies designed to directly elicit within patients a response of antigen-specific killer T-cells and antibodies, thereby activating essential imm...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
4.43% Jun 01
N
NVRI
$19.53
0.87% May 20
RUN
$12.83
15.51% May 06
GLBE
$31.61
4.05% May 05
SAP
$172.39
8.56% May 05

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE